News & Research

Home|Category: News & Research ( Page 7 )

Cognitive phenotypes in multiple sclerosis.

For the Journal of Neurology, Dr. Leavitt and team investigated a novel taxonomy for describing specific cognitive changes in people living with MS, to advance our understanding beyond the traditional “impaired” or “not impaired” descriptors. J Neurol. 2018 March Authors: Leavitt VM, Tosto G, Riley CS.

Friday Music With Paul.

Writing in the Journal of the American Medical Association (JAMA Neurology), Dr. Leavitt shares her personal account of how music became a part of the treatment plan for one person living with MS. JAMA Neurol. Nov 1, 2017. Leavitt VM & Tunick, P.

Aspirin is an effective pretreatment for exercise in multiple sclerosis: A double-blind randomized controlled pilot trial.

Dr. Leavitt’s pilot trial employing aspirin as a simple, inexpensive cooling method to improve exercise performance for people living with MS was reported in Multiple Sclerosis Journal, written up on the Multiple Sclerosis Hub on MD Edge, and presented at the 2017 ECTRIMS conference in Paris. Mult Scler. Oct 1, 2017 Authors: Leavitt VM, Blanchard AR, Guo CY, Gelernt E, Sumowski JF, Stein J.

Characterizing cognitive impairment in multiple sclerosis: an essential step towards prediction and prevention.

Penning a position piece for the European Journal of Neurology, Dr. Leavitt and team promote new priorities to further the goal of ultimately developing effective treatments for cognition in people living with MS. Eur J Neurol. Feb 23, 2016. Authors: Leavitt VM, Sumowski JF.